Utilization of endogenous albumin trafficking pathways in the lungs has potential to modestly increase the lung interstitial access and absorption of drug delivery systems after inhaled administration-Reference-Cited by-同舟云学术

Utilization of endogenous albumin trafficking pathways in the lungs has potential to modestly increase the lung interstitial access and absorption of drug delivery systems after inhaled administration

Published:2023-08-03 Issue:8 Volume:20 Page:1145-1155
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Ibrahim Jibriil P¹,Butcher Neville J¹,Kothapalli Ashok¹,Subasic Christopher N¹,Blanchfield Joanne T²,Whittaker Andrew K.³⁴,Whittaker Michael R⁵^ORCID,Kaminskas Lisa M¹

Affiliation:

1. School of Biomedical Sciences, University of Queensland, St Lucia, QLD, Australia

2. School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, QLD, Australia

3. Australian Institute of Bioengineering and Nanotechnology, University of Queensland, St Lucia, QLD, Australia

4. Australian Research Council Centre of Excellence for Green Electrochemical Transformation of Carbon Dioxide, University of Queensland, St Lucia, QLD, Australia

5. Drug Delivery Disposition Dynamics, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, Australia

Funder

National Health and Medical Research Council

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2023.2244881

Reference49 articles.

1. Inhaling medicines: delivering drugs to the body through the lungs

2. The Lungs as a Portal of Entry for Systemic Drug Delivery

3. Optimal Antibiotic Dosing: The pharmacokinetic-pharmacodynamic

4. Disposition and safety of inhaled biodegradable nanomedicines: Opportunities and challenges

5. Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipidated brush-PEG polymers as low molecular weight pulmonary drug delivery platforms;Expert Opinion on Drug Delivery;2024-01-02

2. Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity;Biomaterials Science;2024